Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas-Reference-Cited by-同舟云学术

Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas

Published:2020-09 Issue: Volume:137 Page:10-17
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Franceschi Enrico,Tosoni Alicia,Bartolini Stefania,Minichillo Santino,Mura Antonella,Asioli Sofia,Bartolini Daniela,Gardiman Marina,Gessi Marco,Ghimenton Claudio,Giangaspero Felice,Lanza Giovanni,Marucci Gianluca,Novello Mariangela,Silini Enrico M.,Zunarelli Elena,Paccapelo Alexandro,Brandes Alba A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. The 2016 World Health organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol,2016

2. IDH1 and IDH2 mutations in gliomas;Yan;N Engl J Med,2009

3. IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival;Leu;Neuro Oncol,2013

4. Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning;Suchorska;Eur J Canc,2019

5. Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways;Halani;NPJ Precis Oncol,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting oligodendroglioma grading in the 2021 WHO classification: calcification and larger contrast-enhancing tumor volume may predict higher oligodendroglioma grade;Neuroradiology;2024-07-17

2. Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study;Clinical Cancer Research;2024-07-11

3. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?;Neuro-Oncology;2024-06-24

4. Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resection;Annals of Clinical and Translational Neurology;2024-06-24

5. The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index;Acta Radiologica;2024-04-22